News | Heart Failure | December 16, 2021

First-Of-Its-Kind Medicare Advantage Plan Addresses Diabetics With Heart Failure

New York and Vermont plan is one of three plans in the country to offer free, level 3 cardiac rehab

First-Of-Its-Kind Medicare Advantage Plan Addresses Diabetics With Heart Failure. Getty images

Getty images


December 16, 2021 — MVP Health Care and The University of Vermont Health Network recently announced their joint Medicare Advantage Plan, called UVM Health Advantage, will offer older adults in Northern New York and Vermont support for their two biggest health concerns: heart disease and diabetes. The plan provides 3 months of free medically tailored meals for those diagnosed with congestive heart failure, up to 36 free rides to or from medical appointments, a digital blood pressure cuff and pulse oximeter, low-cost orthotics and diabetic shoes, and more. Members of UVM Health Advantage will also have access to MVP’s vast network of physicians across Vermont and New York.

“UVM Health Advantage delivers a completely new Medicare Advantage experience – one that’s simpler, easier to use, and designed with our members and their physicians,” said MVP Health Care’s president and Chief Executive Officer, Christopher Del Vecchio. “We’re proud to pioneer this vision in partnership with UVM Health Network, which offers bold options for fighting two wide-spread conditions that older adults are facing.”

According to the CDC, heart disease is the leading cause of death in New York and Vermont, which is why UVM Health Advantage is supporting older adults as they navigate their health journey against this condition. Cardiac rehab level 3, which is designed to maintain a healthier lifestyle through supervised exercise sessions and health education, is covered at no cost — one of only three insurance plans in the country to so. Additionally, studies have shown the link between good dental hygiene and cardiac care — which is why UVM Health Advantage also offers robust dental benefits to its members.

Diabetes was also a top concern among older adults in the region, as more than 1.7 million New Yorkers and more than 55,000 Vermonters have been diagnosed with the condition. UVM Health Advantage covers routine podiatry visits, provides a glucometer and related supplies, includes low-cost orthotics and diabetic shoes, and free gym memberships to support in living a healthier lifestyle.

“We know that heart disease and diabetes can be successfully managed if patients have the right tools and support they need,” said John R. Brumsted, M.D., president and CEO of The University of Vermont Health Network. “We are excited about our partnership with MVP to offer a plan that can help older adults in our region live healthier lives.”

For more information: www.uvmhealthadvantage.com

Related Content

Videos | Heart Failure

The University of Maryland Medical Center (UMMC) announced the first successful transplant of a genetically modified pig ...

Home January 11, 2022
Home
Feature | Heart Failure | By Dave Fornell, DAIC Editor

January 10, 2022 — The University of Maryland School of Medicine (UMSOM) and the University of Maryland Medical Center ...

Home January 10, 2022
Home
News | Heart Failure

November 19, 2021 — Adults treated with empagliflozin during hospitalization for acute heart failure experienced a ...

Home November 19, 2021
Home
News | Heart Failure

November 17, 2021 — Canagliflozin, a medication used to treat type 2 diabetes, was found to greatly improve symptoms and ...

Home November 17, 2021
Home
News | Heart Failure

November 10, 2021 — Ancora Heart Inc., a company developing a novel therapy to address heart failure, announced results ...

Home November 10, 2021
Home
News | Heart Failure

November 2, 2021 — Cardionomic Inc. announce initial U.S. enrollment in its global Cardiac Pulmonary Nerve Stimulation ...

Home November 02, 2021
Home
News | Heart Failure

October 27, 2021 — Impulse Dynamics announced the U.S. Food and Drug Administration approved a modification of labeling ...

Home October 27, 2021
Home
News | Heart Failure

October 1, 2021 — A pooled analysis of two randomized trials has demonstrated the beneficial effects of empagliflozin in ...

Home October 04, 2021
Home
News | Heart Failure

September 28, 2021 — Hemodynamic guided management using the CardioMEMS device may reduce heart failure hospitalizations ...

Home September 28, 2021
Home
News | Heart Failure

September 22, 2021 — A cardiothoracic surgical team with University of Louisville Health – Jewish Hospital has performed ...

Home September 22, 2021
Home
Subscribe Now